CODX (Co-Diagnostics Corp) יחס שווי שוק לשווי בספרים

Historical price action for Co-Diagnostics, Inc. (CODX) demonstrates independence from market fluctuations, as the business relies on the production of advanced medical products and the success of clinical tests, with the metric standing at 0.18. Diagnostic reliability is ensured through the implementation of Co-Primers, which eliminate errors in results. Despite an oversupply of offerings in the sector, Co-Diagnostics, Inc. (CODX) maintains its position through patents for AI-based home rapid-test systems.

Co-Diagnostics, Inc. (CODX) dominates molecular diagnostics through unique patented methods of ultra-precise PCR analysis. This metric compares the current market value of shares with the issuer's net assets. Investors use this ratio to determine whether the business is overbought or undervalued relative to its tangible asset base. A stable range of values confirms fair market pricing. Analyzing the premium of the market valuation over the book value allows for the identification of hidden risks or growth potential.